On February 26, 2008, Genuity changed their recommendation from a hold to a buy. At that time, the share price was $5.04 and soon thereafter, we were at their target price of $7.00.
They have once again changed their recommendation to a buy with an unchanged target price of $7.00. Keep in mind that this target price was based upon visuals of DE2.
Favorable assays and or additional visuals of DE2 of discovery of DE3 will blow their target price out of the water.
I was wrong about expected strength at the end of trade on Thursday and as such take my suggestion that we will close strongly today with a grain of salt.
Cheers,
Milsy1